Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | Berman Howard Chief Executive Officer 10% Owner |
10,000 | $0 | $0 | 964,338 (Indirect Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | Lee Ann Director |
10,000 | $0 | $0 | 32,437 (Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | Hepner Adrian Chief Medical Officer |
10,000 | $0 | $0 | 15,000 (Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | Garren Hideki Director |
2,000 | $0 | $0 | 3,000 (Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | SNYDER DAVID S Chief Financial Officer |
7,000 | $0 | $0 | 10,500 (Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | Villalobos Anabella Director |
10,000 | $0 | $0 | 15,000 (Direct) |
View |
2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
10,000 | $0 | $0 | 15,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-03 Conversion |
2023-01-04 08:30 am |
N/A N/A |
Coya Therapeutics Inc. | COYA | Lee Ann Director |
25,000 | $0 | 32,437 (Direct) |
View |
2023-01-03 Conversion |
2023-01-04 08:30 am |
N/A N/A |
Coya Therapeutics Inc. | COYA | Lee Ann Director |
6,479 | $4 | 32,437 (Direct) |
View |
Ownership |
2022-12-28 9:40 pm |
N/A N/A |
Coya Therapeutics Inc. | COYA | Bertex LLC 10% Owner |
0 | $0 | 939,338 (Direct) |
View |
Ownership |
2022-12-28 8:47 pm |
N/A 2032-06-28 |
Coya Therapeutics Inc. | COYA | SNYDER DAVID S Chief Financial Officer |
0 | $0 | 87,788 (Direct) |
View |
Ownership |
2022-12-28 8:43 pm |
2021-07-01 2031-06-10 |
Coya Therapeutics Inc. | COYA | Lee Ann Director |
0 | $0 | 24,002 (Direct) |
View |
Ownership |
2022-12-28 8:39 pm |
2022-05-01 2031-04-10 |
Coya Therapeutics Inc. | COYA | Garren Hideki Director |
0 | $0 | 17,557 (Direct) |
View |
Ownership |
2022-12-28 8:38 pm |
2022-11-01 2031-10-31 |
Coya Therapeutics Inc. | COYA | Hepner Adrian Chief Medical Officer |
0 | $0 | 87,921 (Direct) |
View |
Ownership |
2022-12-28 8:38 pm |
2021-04-01 2031-03-30 |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
0 | $0 | 17,557 (Direct) |
View |
Ownership |
2022-12-28 8:37 pm |
N/A N/A |
Coya Therapeutics Inc. | COYA | Berman Howard Chief Executive Officer 10% Owner |
0 | $0 | 939,338 (Indirect) |
View |
Ownership |
2022-12-28 8:36 pm |
2021-07-01 2031-06-07 |
Coya Therapeutics Inc. | COYA | Villalobos Anabella Director |
0 | $0 | 17,557 (Direct) |
View |